Type 2 Diabetes

The American Diabetes Association has adopted the 2013 ACC/AHA cholesterol guidelines in its 2015 Standards of Care -- but not entirely.

Several trials have been conducted, and many more are yet to be completed, that have the goal of addressing whether intensive blood glucose control and intensive blood pressure (BP) control have any long-term benefit on all-cause mortality and major cardiovascular events. Contradictory data have been published with respect to the short- and long-term benefits of aggressive BP and blood glucose control versus conventional treatments for BP and glucose control. This review presents the main points of some of the important trials to date on this subject.

The Food and Drug Administration said Friday it has approved the use of Lucentis (ranibizumab injection) 0.3 mg to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME).

The 3 FDA-approved sodium glucose co-transporter 2 inhibitors remain under close post-marketing scrutiny. These 7 slides distill for you all the cancer risk information to date.

Researchers saw a rapid and durable response to the addition of albiglutide in T2DM patients not reaching glycemic targets on dual oral therapy.

As the National Institute of Health's National Diabetes Education Program (NDEP) institutes a new strategic plan, the group also welcomes a new leader who is familiar with the goals of the program.

The Food and Drug Administration has approved a new medication to improve glycemic control in adults with type 2 diabetes.

Pre-surgical weight loss in obese patients with type 2 diabetes reduces perioperative risk. The dual benefits of GLP-1 agonists offer promise to this hard-to-treat population.

Regulation of glucose homeostasis by the kidney is impaired in persons with type 2 diabetes. Find out what you know about this renal dysfunction and the role of SGLT2 inhibition in reducing hyperglycemia.

The "inverted champagne bottle" appearance of the distal leg is a specific finding associated with this condition. Lipodermatosclerosis usually occurs in patients with long-standing venous insufficiency.

The new guidelines signal a shift toward aggressive treatment for obesity as a primary disease and following with treatment for comorbidites that do not respond to weight loss.

JAMA Psychiatry has published a study ahead of print examining the relationship between PTSD and T2DM in Nurses' Health Study II participants. The study questioned whether PTSD increased the risk of T2DM among civilians, and the magnitude of change. The findings indicated a positive association.

Long-term use of this SGLT2 inhibitor revealed sustained clinical benefits in older patients with diabetes and most AEs reported were mild.

In the wake of Joan Rivers' untimely death last year, ambulatory surgery centers have come under increased scrutiny. Several recent articles in the literature look at this complicated area of surgical practice.

SGLT2 inhibitors perform well in older patients and cause minimal hypoglycemia. But caution is advised and here are 5 reasons why.

The incidence and mortality of pancreatic adenocarcinoma, the fourth leading cause of cancer deaths in the United States, are both on the rise. Globally, the disease is responsible for 227,000 deaths annually. Researchers from the National Taiwan University College of Medicine recently published a meta-analysis that demonstrated a dose-response relationship between fasting blood glucose levels and pancreatic cancer risk. They also examined the link between prediabetes and pancreatic cancer risk.

Researchers at the University of Missouri and the National Research Council in Padova, Italy, recently investigated the role that timing of resistance exercise plays in lowering cardiovascular risk. They wondered if the time of day when diabetics exercise could explain the lower-than-expected exercise-derived benefits seen in some diabetics.

Prolonged sitting is a health hazard even when people exercise regularly, a new Canadian study has found. Writing in Annals of Internal Medicine, David Alter, MD, PhD, and colleagues quantified the association between sedentary time and negative health outcomes. Those included hospitalizations, mortality, cardiovascular disease, diabetes and cancer in adults.

Endo Tools, Endo Pubs, Glooko--just a few of the mobile apps described here, all designed specifically for the clinical endocrinologist.

The US Food and Drug Administration (FDA) recently announced the approval of a device to help treat patients with obesity.

Researchers in Scotland have shown that while diabetes is a growing problem for that country's population, patients diagnosed with the condition are living considerably longer than they would have in the past. This is particularly true for patients diagnosed with type 1 diabetes.

Three-quarters of persons with diabetes will experience significant gastrointestinal symptoms. What underlies the evolution of these GI ailments?

Diabetic polyneuropathy (DPN) can exist with or without neuropathic pain. Roughly half of patients with types I and II diabetes mellitus (DM) develop DPN. In type 1 DM, patients start to notice symptoms of distal polyneuropathy after many years of chronic prolonged hyperglycemia. It's more aggressive in type 2 DM, and can develop after only a few years of known poor glycemic control and may be present at diagnosis.

Which one of these four liver disorders is not associated with diabetes mellitus?

Who’s in charge of a multidisciplinary team caring for a single patient? Ideally it shouldn’t matter if-and it’s a big if-members can communicate and work together.

With a new year comes New Year's resolutions, many of which involve getting healthy in the year ahead. A recent study has shown that by keeping those resolutions people can not only lose the weight they want but also avoid other health issues like diabetes.

A Swedish population study found that following through on typical New Year's resolutions to eat better, quit smoking, and exercise more has a significant impact on incidence of diabetes.

Obesity and physical activity have become a focus of the healthcare community in the recent past and that was no exception in 2014. Over the past 12 months we have highlighted advancements in the treatment, diagnosis and impact of diabetes on our daily lives. Here is a look at the top 10 stories from the year.